InsiderTrades.com logo
Elon’s New Device is About to Shock the World
From InvestorPlace   |   Ad
Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.”
Click here to see the details because there’s a lot of money at stake.
Become an InsiderTrades.com Insider.
Create a FREE account to receive daily insider buying & selling reports.
Sign Up (FREE)

Recent Insider Transactions from Notable Insiders

CompanyInsider NameBuy/SellShares Bought/SoldTotal TransactionShares Held After TransactionTransaction DateDetails
NASDAQ:GOOGL
Alphabet		Amie Thuener O'Toole
CAO		Sell682$125,126.54 30,6507/2/2024View SEC Filing Icon
NASDAQ:PBYI
Puma Biotechnology		Maximo F. Nougues
CFO		Sell5,295$17,314.65 166,6787/2/2024View SEC Filing Icon
NASDAQ:GOOG
Alphabet		Amie Thuener O'toole
CAO		Sell682$125,126.54 30,6507/2/2024View SEC Filing Icon
NASDAQ:MORN
Morningstar		Jason Dubinsky
CFO		Sell3,400$1,020,374.00 20,1817/2/2024View SEC Filing Icon
NYSE:FDX
FedEx		David P. Steiner
Director		Sell1,369$407,564.99 35,1837/2/2024View SEC Filing Icon
NASDAQ:PBYI
Puma Biotechnology		Alan H. Auerbach
CEO		Sell18,885$61,753.95 7,085,4357/2/2024View SEC Filing Icon
NASDAQ:WLFC
Willis Lease Finance		Brian Richard Hole
President		Sell293$20,439.68 100,7647/1/2024View SEC Filing Icon
NASDAQ:PRTH
Priority Technology		Sean Kiewiet
Insider		Sell2,804$14,020.00 1,193,5167/1/2024View SEC Filing Icon
NASDAQ:GOOGL
Alphabet		Prabhakar Raghavan
SVP		Sell3,262$600,175.38 97/1/2024View SEC Filing Icon
NASDAQ:AKRO
Akero Therapeutics		Jonathan Young
COO		Sell5,000$117,000.00 246,8547/1/2024View SEC Filing Icon
NASDAQ:NVDA
NVIDIA		Jen Hsun Huang
CEO		Sell120,000$14,733,600.00 79,974,9957/1/2024View SEC Filing Icon
NASDAQ:GTLB
GitLab		Brian G. Robins
CFO		Sell23,334$1,172,300.16 282,4417/1/2024View SEC Filing Icon
NASDAQ:GILD
Gilead Sciences		Merdad Parsey
Insider		Sell2,000$137,260.00 96,3807/1/2024View SEC Filing Icon
NASDAQ:BCDA
BioCardia		Peter Altman
CEO		Buy300$915.00 39,7457/1/2024View SEC Filing Icon
NASDAQ:AFRM
Affirm		Keith Rabois
Director		Sell9,276$277,259.64 73,6237/1/2024View SEC Filing Icon
NYSE:FDS
FactSet Research Systems		Philip Snow
CEO		Sell3,000$1,226,940.00 12,9157/1/2024View SEC Filing Icon
NASDAQ:NFLX
Netflix		Reed Hastings
Chairman		Sell22,526$15,103,457.74 577/1/2024View SEC Filing Icon
NYSE:HRB
H&R Block		Jeffrey J. Jones, II
CEO		Sell44,975$2,453,386.25 712,3867/1/2024View SEC Filing Icon
NYSE:AGR
Avangrid		Alan D. Solomont
Director		Buy141$5,030.88 11,0247/1/2024View SEC Filing Icon
NASDAQ:PANW
Palo Alto Networks		William D. Jenkins, Jr
President		Sell1,475$500,202.00 19,0267/1/2024View SEC Filing Icon
See Full Table
Major Pharma Deals Propel This Undervalued AI Stock
From Behind the Markets   |   Ad
You need to check out this game-changing biotech stock. Their physics-based software can model how molecules behave and identify ideal drug candidates in record time. Big Pharma is taking notice.
Reveal the AI Company Disrupting Drug Discovery Here >>>

Recently Disclosed Insider Trades

CompanyInsider NameBuy/SellShares Bought/SoldTotal TransactionShares Held After TransactionTransaction DateDetails
NASDAQ:AADI
Aadi Bioscience		Neil Desai
Chairman		Sell31,348$45,454.60 1,260,1957/1/2024View SEC Filing Icon
NYSE:PEO
Adams Natural Resources Fund		Saba Capital Management, L.P.
Major Shareholder		Buy26,730$630,560.70 2,725,2977/1/2024View SEC Filing Icon
NASDAQ:AEIS
Advanced Energy Industries		Anne DelSanto
Director		Sell148$16,055.04 7,0177/1/2024View SEC Filing Icon
NYSE:ASIX
AdvanSix		Achilles B Kintiroglou
SVP		Sell350$8,050.00 34,6517/1/2024View SEC Filing Icon
NASDAQ:AVAV
AeroVironment		Kevin Patrick Mcdonnell
CFO		Sell511$91,187.95 21,3347/1/2024View SEC Filing Icon
NASDAQ:AFRM
Affirm		Keith Rabois
Director		Sell9,276$277,259.64 73,6237/1/2024View SEC Filing Icon
NASDAQ:AKRO
Akero Therapeutics		Jonathan Young
COO		Sell5,000$117,000.00 246,8547/1/2024View SEC Filing Icon
NASDAQ:ALLK
Allakos		Harlan Baird Radford
CFO		Sell87,064$87,934.64 204,3906/28/2024View SEC Filing Icon
NYSE:ALSN
Allison Transmission		John Coll
SVP		Sell2,000$150,120.00 14,4206/28/2024View SEC Filing Icon
NASDAQ:GOOG
Alphabet		Prabhakar Raghavan
SVP		Sell3,262$600,175.38 97/1/2024View SEC Filing Icon
See All Recent Insider Trades
Major Pharma Deals Propel This Undervalued AI Stock
From Behind the Markets   |   Ad
You need to check out this game-changing biotech stock. Their physics-based software can model how molecules behave and identify ideal drug candidates in record time. Big Pharma is taking notice.
Reveal the AI Company Disrupting Drug Discovery Here >>>

Most Active Insiders (Last 90 Days)

Insider NameCompanyRecent TransactionsSize of Recent TransactionsShares BoughtShares Sold
Murray Stahl
CEO		NYSE:RCG
RENN Fund		37$657.313980
Telekom Ag Deutsche
Director		NASDAQ:TMUS
T-Mobile US		36$1,092,872,500.3306,532,200
David Michael Barrett
CEO		NASDAQ:EXFY
Expensify		35$809,196.560518,673
Fund 1 Investments, Llc
Major Shareholder		NASDAQ:TTSH
Tile Shop		28$6,234,218.69937,6660
Marc R Benioff
CEO		NYSE:CRM
Salesforce		28$115,524,750.000420,000
Fund 1 Investments, Llc
Major Shareholder		NASDAQ:CTRN
Citi Trends		27$10,837,952.45489,1260
Martine A Rothblatt
Director		NASDAQ:UTHR
United Therapeutics		27$30,609,563.000118,128
See More Active Insiders
Major Pharma Deals Propel This Undervalued AI Stock
From Behind the Markets   |   Ad
You need to check out this game-changing biotech stock. Their physics-based software can model how molecules behave and identify ideal drug candidates in record time. Big Pharma is taking notice.
Reveal the AI Company Disrupting Drug Discovery Here >>>

Top Traded Sectors

Most Bought Companies

Most Sold Companies

This page was last refreshed on Wednesday at 12:32 AM ET.
Elon’s New Device is About to Shock the World
From InvestorPlace   |   Ad
Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.”
Click here to see the details because there’s a lot of money at stake.